ARISE-A Chinese Real-world Study of Rimegepant for the Acute Treatment of Migraine
NCT06439628
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
3000
Enrollment
OTHER
Sponsor class
Conditions
Migraine
Interventions
DRUG:
Rimegepant
Sponsor
Chinese PLA General Hospital